David Ricks - CEO of Eli Lilly | Podcast | In Good Company | Norges Bank Investment Management

Eli Lilly CEO: The Weight-Loss Drug Revolution, AI in Pharma, and Innovation

Nicolai Tangen meets with David Ricks, CEO of Eli Lilly, for a discussion about the pharmaceutical giant's remarkable journey. At the forefront is Eli Lilly's breakthrough work with weight reduction drugs, which are showing promise far beyond their original purpose - from treating addiction to potentially impacting Alzheimer's. Ricks reveals how the company has revolutionized drug development by cutting traditional timelines in half, how it navigates global market challenges, and how it approaches drug pricing and innovation. A must-listen for anyone curious about the future of medicine!

In Good Company is hosted by Nicolai Tangen, CEO of Norges Bank Investment Management. New episode out every Wednesday.

The podcast In Good Company is part of Norges Bank Investment Management, a podcast about our investments. We are transparent about how the fund is invested. In this podcast, you get a deeper insight into the companies the fund is invested in.

Our CEO, Nicolai Tangen, has in-depth interviews with the leaders of some of the largest companies in the world. You will get insight into their leadership principles, the company’s strategy and how they are dealing with a large investor like us. You will also learn more about our role as an owner of the companies.

You can read more about the podcast on https://www.nbim.no/en/publications/p...